Search Results1-19 of  19

  • CHOU TAKAAKI ID: 9000253042452

    The First Department of Internal Medicine, Niigata University School of Medicine (1983 from CiNii)

    Articles in CiNii:1

    • Progression of Wenckebach type A-V block to high degree A-V block in aged man. (1983)
  • CHOU Takaaki ID: 1000080227347

    Articles in CiNii:80

    • A Multicenter Early Phase II Study of High-dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation for Treatment of Intermediate-grade Non-Hodgkin's Lymphoma (1999)
    • Pharmacokinetic Study of Etoposide(VP-16) in the High-dose Chemotherapy with Peripheral Blood Stem Cell Transplantation(PBSCT) (1997)
    • Primitive neuroectodermal tumor of the uterine corpus. A case report (2000)
  • CHOU Takaaki ID: 9000000480400

    The Department of Medicine (II), Niigata University Medical School (1995 from CiNii)

    Articles in CiNii:1

    • Adopitive Immunotherapy for Primary Lung Cancer (1995)
  • CHOU Takaaki ID: 9000000733643

    Division of Internal Medicine, Niigata Cancer Center Hospital (1998 from CiNii)

    Articles in CiNii:2

    • Proportion of blasts with a clear halo around nucleoli at the end of induction therapy of acute myeloid leukemia correlates with achievement of complete remission, remission duration and relapse (1998)
    • Detection of circulating tumor cells in a patient with intravascular lymphomatosis : A case study examined by the cytology method (1998)
  • CHOU Takaaki ID: 9000011183334

    Department of Internal Medicine, Niigata Cancer Center Hospital (2012 from CiNii)

    Articles in CiNii:13

    • Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301 (2004)
    • Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study (2004)
    • Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Multiple Myeloma : Results from the Japan Myeloma Study Group (2005)
  • CHOU Takaaki ID: 9000017177774

    Department of Internal Medicine, Niigata Cancer Center Hospital (2009 from CiNii)

    Articles in CiNii:1

    • Phase I/II study of tandem high-dose chemotherapy with autologous peripheral blood stem cell transplantation for advanced multiple myeloma (2009)
  • CHOU Takaaki ID: 9000022105601

    the Department of Medicine (II), Niigata University Medical School (1992 from CiNii)

    Articles in CiNii:1

    • Malignant Lymphoma Localized in the Abdomen. Detection of Ig Gene Rearrangement from the Specimen Obtained by Percutaneous Lymph Node Biopsy. (1992)
  • CHOU Takaaki ID: 9000248231968

    Department of Internal Medicine, Niigata Cancer Center Hospital (2012 from CiNii)

    Articles in CiNii:1

    • Multiple Myeloma : Recent Progress in Diagnosis and Treatment (2012)
  • CHOU Takaaki ID: 9000258035022

    Department of Medicine (II), Niigata University School of Meidicne (1991 from CiNii)

    Articles in CiNii:1

    • Successful Treatment of non-Hodgkin's Lymphoma with Consciousness Disturbance Due to Hypercalcemia by the Calcium-free Hemodialysis and Combined Chemotherapy (1991)
  • CHOU Takaaki ID: 9000258036077

    Department of Medicine (II), Niigata Univ Medical School (1992 from CiNii)

    Articles in CiNii:1

    • Treatment of a CML with Blastic Crisis by the Combination Therapy of VP and Low-dose Ara-C (1992)
  • CHOU Takaaki ID: 9000258040024

    Japan Blood Cell Transplantation Study Group (1999 from CiNii)

    Articles in CiNii:1

    • A Multicenter Early Phase II Study of High-dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation for Treatment of Intermediate-grade Non-Hodgkin's Lymphoma (1999)
  • CHOU Takaaki ID: 9000345434399

    Department of Internal Medicine, Niigata Cancer Center Hospital (2016 from CiNii)

    Articles in CiNii:1

    • Long-term follow-up results of a phase I/II study of melphalan, prednisolone and bortezomib in Japanese transplant-ineligible multiple myeloma patients (JPN-102) (2016)
  • CHOU Takaaki ID: 9000376944082

    Department of Internal Medicine, Niigata Cancer Center Hospital (2017 from CiNii)

    Articles in CiNii:1

    • Lenalidomide and low-dose dexamethasone therapy for Japanese patients with newly diagnosed multiple myeloma: updated results of the MM-025 study (2017)
  • Chou Takaaki ID: 9000254177604

    Department of Medicine (II), Niigata University School of Medicine (1992 from CiNii)

    Articles in CiNii:1

    • Treatment of Advanced Non-small Cell Lung Cancer with the Combination of Systemic Chemotherapy and Adoptive Immunotherapy. (1992)
  • Chou Takaaki ID: 9000254177693

    Department of Medicine (II), Niigata University Medical School (1992 from CiNii)

    Articles in CiNii:1

    • A Case of Pulmonary Diffuse Small Cell B Cell Type Malignant Lymphoma Associated with Biclonal Gammopathy. (1992)
  • Chou Takaaki ID: 9000255947843

    The First Department of Internal M edicine. Niigata University School of Medicine (1982 from CiNii)

    Articles in CiNii:1

    • Progression of advanced A-V block from Wenckebach type A-V block in an aged man.:-Stuyd by Holter ECG and inctracardiac recordings- (1982)
  • Chou Takaaki ID: 9000257910049

    Department Internal Medicine, Niigata Cancer Center Hospital (2005 from CiNii)

    Articles in CiNii:1

    • Isolation and Transplantation of Highly Purified Autologous Peripheral CD34+ Progenitor Cells: Purging Efficacy, Hematopoietic Reconstitution Following High dose Chemotherapy in Patients with Breast Cancer: Results of a Feasibility Study in Japan (2005)
  • Chou Takaaki ID: 9000258051380

    Department of Internal Medicine, Niigata Prefectural Cancer Center Hospital (2012 from CiNii)

    Articles in CiNii:1

    • Evaluation of Adverse Events in Patients with Bortezomib Concomitantly used with Azole-based Antifungal Agents (2012)
  • Chou Takaaki ID: 9000386384872

    Department of Internal Medicine, Niigata Cancer Center Hospital, Japan (2018 from CiNii)

    Articles in CiNii:1

    • A Phase I/II Study for Dose-finding, and to Investigate the Safety, Pharmacokinetics and Preliminary Efficacy of NK012, an SN-38-Incorporating Macromolecular Polymeric Micelle, in Patients with Multiple Myeloma (2018)
Page Top